Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pyroptosis-related signatures predict immune characteristics and prognosis in IPF. | Heliyon | 2024 | 38192798 | PubTator, text mining | PubMed |
| Extrahelical Binding Site for a 1H-Imidazo[4,5-c]quinolin-4-amine A3 Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7. | Mol Pharmacol | 2024 | 38182432 | PubTator, text mining | PubMed |
| The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma. | Aging (Albany NY) | 2024 | 38180750 | PubTator, text mining | PubMed |
| Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies. | Commun Med (Lond) | 2024 | 38172536 | PubTator, text mining | PubMed |
| Differential Gene Expression of SARS-CoV-2 Positive Bronchoalveolar Lavages: A Case Series. | Pathobiology | 2024 | 37490884 | PubTator, text mining | PubMed |
| The double-edged sword of adenosine. | Haematologica | 2024 | 37470140 | PubTator, text mining | PubMed |
| Adenosine signaling inhibits erythropoiesis and promotes myeloid differentiation. | Haematologica | 2024 | 37199120 | PubTator, text mining | PubMed |
| Covalently Binding Adenosine A3 Receptor Agonist ICBM Irreversibly Reduces Voltage-Gated Ca2+ Currents in Dorsal Root Ganglion Neurons. | Purinergic Signal | 2024 | 36918461 | PubTator, text mining | PubMed |
| Gene regulation in activated microglia by adenosine A3 receptor agonists: a transcriptomics study. | Purinergic Signal | 2024 | 36703008 | PubTator, text mining | PubMed |
| Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity? | J Pers Med | 2023 | 38248751 | PubTator, text mining | PubMed |
| Promising antimalarial hits from phenotypic screens: a review of recently-described multi-stage actives and their modes of action. | Front Cell Infect Microbiol | 2023 | 38162576 | PubTator, text mining | PubMed |
| Microglial Senescence and Activation in Healthy Aging and Alzheimer's Disease: Systematic Review and Neuropathological Scoring. | Cells | 2023 | 38132144 | PubTator, text mining | PubMed |
| The interaction of mast cells with membranes from lung cancer cells induces the release of extracellular vesicles with a unique miRNA signature. | Sci Rep | 2023 | 38057448 | PubTator, text mining | PubMed |
| Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis. | Front Endocrinol (Lausanne) | 2023 | 38053725 | PubTator, text mining | PubMed |
| Relevance of Phytochemical Taste for Anti-Cancer Activity: A Statistical Inquiry. | Int J Mol Sci | 2023 | 38003415 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
| Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors. | Biomolecules | 2023 | 38002292 | PubTator, text mining | PubMed |
| Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways. | Biomolecules | 2023 | 38002266 | PubTator, text mining | PubMed |
| Navigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends. | Expert Opin Ther Targets | 2023 | 37997278 | PubTator, text mining | PubMed |
| A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis. | Front Immunol | 2023 | 37954610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=6